SOPs for Injectables V 2.0

This SOP outlines the method for conducting sterility testing of injectable products to detect the presence of viable microorganisms in sterile pharmaceutical preparations using validated test procedures as per pharmacopoeial standards.
Click to read the full article.

To describe the procedure for performing bacterial endotoxin testing (BET) on intravenous (IV) injectable drug products to ensure they comply with pharmacopeial limits using gel clot or chromogenic LAL test methods.
Click to read the full article.

To lay down the procedure for the determination of particulate matter in sterile injectable products using light obscuration and microscopic particle count methods in compliance with USP , EP 2.9.19, and IP guidelines.
Click to read the full article.

This SOP defines the procedure for testing the pH of sterile injectable products to ensure the solution maintains a pH range that meets pharmacopeial requirements and is safe for administration.
Click to read the full article.

This SOP defines the method for performing assay testing of active pharmaceutical ingredients (APIs) present in injectable drug products to confirm their potency and compliance with regulatory and pharmacopeial specifications.
Click to read the full article.

To describe the procedure for visual inspection of sterile injectable products to detect any foreign particles, fibers, or other visual defects and to ensure product clarity before batch release.
Click to read the full article.

This SOP describes the procedure for conducting stability studies on finished sterile injectable products to evaluate their shelf life, storage conditions, and product integrity over time in accordance with ICH guidelines.
Click to read the full article.

To establish a standardized procedure for performing microbial testing of sterile injectable products, including sterility, bioburden, and microbial limits testing, in accordance with pharmacopeial guidelines.
Click to read the full article.

This SOP defines the procedure for performing identity tests on sterile injectable products to confirm the presence of the active pharmaceutical ingredient (API) as declared on the product label, in compliance with pharmacopeial and regulatory requirements.
Click to read the full article.

This SOP outlines the procedure for performing Container Closure Integrity Testing (CCIT) on sterile injectable pharmaceutical products to verify the integrity of packaging systems and ensure product sterility throughout its shelf life.
Click to read the full article.